Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1951
Dingdong
DDL
$481M
| $2.59M | ﹤0.01% |
1,281,700
+227,077
| +22% | +$513K |
2022 Q4
10 quarters
|
|
1952
Capital Group Municipal Income ETF
CGMU
$6.99B
| $2.59M | ﹤0.01% |
+96,919
| New | +$2.57M |
2025 Q2
0 quarters
|
|
1953
Ollie's Bargain Outlet
OLLI
$5.25B
| $2.58M | ﹤0.01% |
19,600
-36,100
| -65% | -$4.13M |
2025 Q1
1 quarter
|
|
1954
Mitek Systems
MITK
$761M
| $2.58M | ﹤0.01% |
260,600
-10,500
| -4% | -$94.3K |
2019 Q1
25 quarters
|
|
1955
NB Bancorp
NBBK
$974M
| $2.57M | ﹤0.01% |
144,148
-58,052
| -29% | -$980K |
2024 Q1
5 quarters
|
|
1956
SiriusPoint
SPNT
$2.93B
| $2.57M | ﹤0.01% |
126,100
-18,800
| -13% | -$346K |
2016 Q3
35 quarters
|
|
|
PHLT
1957
DELISTED
Performant Healthcare Inc
PHLT
| $2.57M | ﹤0.01% |
641,263
-25,100
| -4% | -$71.2K |
2013 Q4
46 quarters
|
|
1958
Capital Group Global Growth Equity ETF
CGGO
$11.9B
| $2.56M | ﹤0.01% |
+80,200
| New | +$2.37M |
2025 Q2
0 quarters
|
|
1959
Vanguard Health Care ETF
VHT
$19.1B
| $2.56M | ﹤0.01% |
+10,300
| New | +$2.55M |
2025 Q2
0 quarters
|
|
1960
Rackspace Technology
RXT
$925M
| $2.56M | ﹤0.01% |
1,998,286
-532,107
| -21% | -$693K |
2022 Q1
13 quarters
|
|
1961
Entrada Therapeutics
TRDA
$189M
| $2.55M | ﹤0.01% |
379,500
+51,015
| +16% | +$410K |
2024 Q2
4 quarters
|
|
1962
Solventum
SOLV
$14.7B
| $2.55M | ﹤0.01% |
33,600
+19,500
| +138% | +$1.38M |
2025 Q1
1 quarter
|
|
1963
Peapack-Gladstone Financial
PGC
$767M
| $2.55M | ﹤0.01% |
90,113
+30,593
| +51% | +$840K |
2013 Q2
48 quarters
|
|
1964
SLM Corp
SLM
$4.27B
| $2.54M | ﹤0.01% |
77,599
-128,401
| -62% | -$3.93M |
2024 Q4
2 quarters
|
|
1965
Security National Financial
SNFCA
$237M
| $2.54M | ﹤0.01% |
284,291
+13,400
| +5% | +$120K |
2014 Q4
42 quarters
|
|
1966
Amylyx Pharmaceuticals
AMLX
$3.37B
| $2.54M | ﹤0.01% |
396,200
-118,900
| -23% | -$578K |
2023 Q3
7 quarters
|
|
1967
Senstar Technologies
SNT
$33.4M
| $2.53M | ﹤0.01% |
535,269
+500
| +0.1% | +$1.84K |
2013 Q2
48 quarters
|
|
1968
Vanguard Russell 1000 Value ETF
VONV
$22.3B
| $2.53M | ﹤0.01% |
29,700
+24,300
| +450% | +$1.98M |
2024 Q3
3 quarters
|
|
1969
Acco Brands
ACCO
$422M
| $2.53M | ﹤0.01% |
706,300
+80,900
| +13% | +$299K |
2021 Q4
14 quarters
|
|
1970
Cullinan Oncology
CGEM
$907M
| $2.52M | ﹤0.01% |
334,525
-28,483
| -8% | -$229K |
2022 Q2
12 quarters
|
|
1971
Hamilton Insurance Group
HG
$3.44B
| $2.52M | ﹤0.01% |
116,500
-308,116
| -73% | -$6.2M |
2024 Q1
5 quarters
|
|
1972
Alpha Pro Tech
APT
$58.8M
| $2.51M | ﹤0.01% |
536,075
-3,484
| -0.6% | -$15.8K |
2013 Q2
48 quarters
|
|
1973
iShares US Technology ETF
IYW
$26.7B
| $2.51M | ﹤0.01% |
+14,500
| New | +$2.2M |
2025 Q2
0 quarters
|
|
1974
Canaan Creative
CAN
$204M
| $2.51M | ﹤0.01% |
4,057,001
+1,184,647
| +41% | +$833K |
2024 Q4
2 quarters
|
|
1975
OneMain Financial
OMF
$6.45B
| $2.51M | ﹤0.01% |
44,000
-146,700
| -77% | -$7.32M |
2024 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.